Education
About Us
Working with TipRanks
Follow Us
Electromed (ELMD)
:ELMD
ELMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$17.73 - $35.56
Previous CloseN/A
Volume34.94K
Average Volume (3M)89.93K
Market Cap
$199.04M
Enterprise Value$176.64M
Total Cash (Recent Filing)$15.29M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)28.1
Beta0.59
Next Earnings
Nov 11, 2025EPS Estimate
0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.25
Shares Outstanding8,349,176
10 Day Avg. Volume100,869
30 Day Avg. Volume89,928
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue2.76
Enterprise Value/Gross Profit3.53
Enterprise Value/Ebitda16.31
Forecast
1Y Price Target
$33.33Price Target Upside43.42% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
EarningsElectromed reported solid Q4 results, above both analysts and the Street, indicating strong execution in the bronchiectasis market.
Growth OutlookElectromed is expected to achieve consistent double-digit revenue growth in the coming years, with operating leverage arising from top-line growth.
Market PotentialA substantial opportunity remains within the diagnosed population, with an estimated 4 million people in the U.S. having undiagnosed bronchiectasis.
Bears Say
Market CompetitionElectromed's leading HFCWO product may face challenges due to limited resources dedicated to it by its parent company.
Resource AllocationThe sales force size and productivity guidance are conservative, with only a 10% expansion in direct salesperson headcount projected.
Electromed News
ELMD FAQ
What was Electromed’s price range in the past 12 months?
Electromed lowest stock price was $17.73 and its highest was $35.56 in the past 12 months.
What is Electromed’s market cap?
Electromed’s market cap is $199.04M.
When is Electromed’s upcoming earnings report date?
Electromed’s upcoming earnings report date is Nov 11, 2025 which is in 46 days.
How were Electromed’s earnings last quarter?
Electromed released its earnings results on Aug 26, 2025. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.217 by $0.033.
Is Electromed overvalued?
According to Wall Street analysts Electromed’s price is currently Undervalued.
Does Electromed pay dividends?
Electromed does not currently pay dividends.
What is Electromed’s EPS estimate?
Electromed’s EPS estimate is 0.21.
How many shares outstanding does Electromed have?
Electromed has 8,349,176 shares outstanding.
What happened to Electromed’s price movement after its last earnings report?
Electromed reported an EPS of $0.25 in its last earnings report, beating expectations of $0.217. Following the earnings report the stock price went up 19.894%.
Which hedge fund is a major shareholder of Electromed?
Currently, no hedge funds are holding shares in ELMD
Electromed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$33.33 (43.42% Upside)
$33.33 (43.42% Upside)
Blogger Sentiment
Bullish
ELMD Sentiment 100%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Decreased
By 10.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 2.3%
Last 30 Days ▼ 2.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.89%
12-Months-Change
Fundamentals
Return on Equity
17.18%
Trailing 12-Months
Asset Growth
3.07%
Trailing 12-Months
Company Description
Electromed
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.
ELMD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Electromed demonstrated strong growth in revenue, profitability, and market presence, reflected in record financial results and strategic initiatives like stock repurchases and increased awareness for bronchiectasis. However, challenges like decreased cash balance and increased expenses were noted. The overall sentiment is positive due to the significant highlights outweighing the lowlights.View all ELMD earnings summariesELMD Stock 12 Month Forecast
Average Price Target
$33.33
▲(43.42% Upside)
Technical Analysis
Ownership Overview
6.93% Insiders
8.88% Mutual Funds
9.06% Other Institutional Investors
67.10% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---